Patient presents with signs and symptoms consistent with thyroid orbitopathy (Graves ophthalmopathy), a clinical manifestation often associated with Graves disease and autoimmune thyroid disorders.  The patient reports experiencing proptosis, eyelid retraction, diplopia, and ocular discomfort.  Clinical examination reveals periorbital edema, conjunctival injection, restrictive extraocular muscle motility specifically impacting upward and lateral gaze, and positive clinical activity score (CAS).  Exophthalmometry measurements document proptosis exceeding normal limits.  Patient denies vision loss.  Assessment includes thyroid function tests (TFTs) including TSH, free T4, and free T3 levels to evaluate thyroid status.  Orbital imaging, such as CT or MRI of the orbits, is ordered to assess the extent of extraocular muscle enlargement and exclude other orbital pathologies.  Differential diagnosis includes orbital pseudotumor, orbital cellulitis, and other inflammatory orbital processes.  Current treatment plan includes artificial tears for dry eye management, selenium supplementation, and smoking cessation counseling.  Patient education provided on the natural course of thyroid orbitopathy and potential complications. Referral to ophthalmology and endocrinology for co-management and consideration for corticosteroids, orbital decompression surgery, or immunomodulatory therapies like teprotumumab depending on disease severity and progression.  ICD-10 code H05.10 is documented for bilateral non-specified thyroid orbitopathy.  Follow-up appointment scheduled to monitor disease activity, treatment response, and address any emergent symptoms like compressive optic neuropathy.